Builds live-cell biosensors and 3D organoid/TR‑FRET platforms for ultra‑high‑throughput screening. Maps cancer interaction networks, coupling genetic and phenotypic screens to prioritize targets and discover small‑molecule modulators of protein–protein interactions.